Mitchell Bonjean, RPH in Mukwonago, WI - Pharmacist

Mitchell Bonjean, RPH is a Pharmacist based in Mukwonago, Wisconsin. Mitchell Bonjean is licensed to practice in Wisconsin (license number 12608-40) and his current practice location is 212 N Rochester St, Mukwonago, Wisconsin. He can be reached at his office (for appointments etc.) via phone at (262) 363-5235.

NPI number for Mitchell Bonjean is 1013290881 and his current mailing address is 212 N Rochester St, Mukwonago, Wisconsin. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1013290881.

Contact Information

	Mitchell Bonjean, RPH
	212 N Rochester St, Mukwonago, WI 53149-1313
	(262) 363-5235
	Not Available

Healthcare Provider's Profile

Full Name	Mitchell Bonjean
Gender	Male
Speciality	Pharmacist
Location	212 N Rochester St, Mukwonago, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1013290881
Provider Enumeration Date: 09/27/2011
Last Update Date: 09/27/2011

Medical Identifiers

Medical identifiers for Mitchell Bonjean such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013290881	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	12608-40 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mitchell Bonjean is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mitchell Bonjean, RPH 212 N Rochester St, Mukwonago, WI 53149-1313 Ph: (262) 363-5235	Mitchell Bonjean, RPH 212 N Rochester St, Mukwonago, WI 53149-1313 Ph: (262) 363-5235

News Archive

Zimbabwe HIV/AIDS organizations call for integration of TB interventions into country's HIV/AIDS programs

The Zimbabwe government should integrate tuberculosis interventions into its HIV/AIDS programs, HIV/AIDS service organizations and other health advocates said at a recent forum hosted by the Southern Africa HIV/AIDS Information Dissemination Service in the country's capital of Harare, the Herald reports.

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.

Fifth patient dosed in Benitec's TT-034 Phase I/IIa clinical trial for prevention of HCV infection

Benitec Biopharma, a biopharmaceutical company focused on providing potentially curative therapies with its proprietary gene-silencing technology called ddRNAi or "expressed RNAi," is pleased to advise that the fifth patient in the company's 'first in man', Phase I/IIa dose escalation clinical trial of TT-034 for hepatitis C virus (HCV) infection, has today, been dosed at the Duke Clinical Research Unit.

Breast density, microcalcifications, and masses are heritable features, analysis reveals

An analysis of a large Swedish cohort revealed that breast density, microcalcifications, and masses are heritable features, and that breast density and microcalcifications were positively associated with a genetic predisposition to breast cancer.

Research reveals major drivers of increased nicotine and tobacco use during COVID-19 lockdown

Pandemic-related anxiety, boredom, and irregular routines were cited as major drivers of increased nicotine and tobacco use during the initial COVID-19 "lockdown," according to research just released by Columbia University's Mailman School of Public Health.

Pharmacist in Mukwonago, WI

Jacob Vance, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 N Rochester St, Mukwonago, WI 53149 Phone: 262-363-5235
Ernest Joseph Tanel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: W312s8764 Meyer Dr, Mukwonago, WI 53149 Phone: 262-363-2286
Joshua Amelunk, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Wolf Run, Mukwonago, WI 53149 Phone: 262-363-8366
Rebecca Scharringhausen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Wolf Run, Mukwonago, WI 53149 Phone: 262-363-8366
Dr. Gurjit Singh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 N Rochester St, Mukwonago, WI 53149 Phone: 262-363-5235
Katherine Seeley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 250 Wolf Run, Mukwonago, WI 53149 Phone: 262-363-8366

Mitchell Bonjean, RPH - Pharmacist in Mukwonago, WI